Full article: Novel multi-target ligands of dopamine and serotonin
Por um escritor misterioso
Descrição
N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands
Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease - ScienceDirect
Frontiers Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
Frontiers Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications
Update on GPCR-based targets for the development of novel antidepressants
Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease - ScienceDirect
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse - Schenk - 2021 - Journal of Neurochemistry - Wiley Online Library
Unraveling the dynamics of dopamine release and its actions on target cells: Trends in Neurosciences
Frontiers Serotonin Receptor and Transporter Endocytosis Is an Important Factor in the Cellular Basis of Depression and Anxiety
Biomolecules, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)